Gland Pharma (GLAND) Share Price rises 2.16% as stock trades at Rs 2,976
- September 3, 2026
- Posted by: Kunal Singla
- Category: News
Gland Pharma Share Price is in focus today after the stock traded at Rs 2,976, up 2.16% from the previous close, with market capitalisation at Rs 47,417.52 crore. The move places Gland Pharma Share Price among the notable pharma names in Indian Stock Market trade today, even though no company-specific catalyst is established. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established.
For readers tracking Gland Pharma Share Price Today, the latest Univest figures show a clean intraday rise with the stock holding above its previous close. That matters because Gland Pharma Stock News is being driven by verified price action rather than a stated event trigger. Investors watching Gland Pharma Share Price Live should note the current levels, the company’s Healthcare backdrop and the valuation metrics that sit alongside the move. Univest data also keeps the focus on how Gland Pharma Share Price compares with Pharmaceuticals & Drugs peers, which is where the next section becomes relevant.
Gland Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,976 |
| Previous Close | Rs 2,913 |
| Today's Move | Rs 63 (+2.16%) |
| Open | Rs 2,917 |
| High | Rs 2,977.4 |
| Low | Rs 2,899.1 |
| Market Capitalisation | Rs 47,417.52 crore |
| Market Cap Category | Large Cap |
Gland Pharma Ltd. (GLAND) rose to Rs 2,976 from the previous close of Rs 2,913, a move of Rs 63 or 2.16%. The stock opened at Rs 2,917, reached a high of Rs 2,977.4, recorded a low of Rs 2,899.1.
Gland Pharma Share Price rose Rs 63 from the previous close and traded at Rs 2,976, marking a 2.16% gain in today’s trade. The stock opened at Rs 2,917, touched a high of Rs 2,977.4 and a low of Rs 2,899.1, so the day’s range has been relatively contained while still showing a firm share price rise. Gland Pharma Share Price Today is therefore best read as a straightforward price move, not as a story built on any unverified trigger. The latest Univest figures confirm that the stock is trading above the previous close and close to the day’s high. For Gland Pharma Share Price readers, the key point is simple: the rise is real, the move is measurable, and the stock remains in active price discovery during market hours.
That price action is the starting point for Gland Pharma Stock Analysis, but the next question is whether the fundamental setup gives the move useful context. Gland Pharma Share Price Today also needs to be read alongside market cap, profitability ratios and sector comparison, because those numbers frame how the stock is valued in relation to the broader pharma universe.
Gland Pharma Ltd. (GLAND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 47,417.52 crore |
| P/E Ratio | 42.58x |
| P/B Ratio | 4.52x |
| ROE | 10.56% |
| ROCE | 14.96% |
| EPS | Rs 68.41 |
| Book Value Per Share | Rs 644.16 |
| Dividend Yield | 0.69% |
Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 42.58x, P/B 4.52x, ROE 10.56%, ROCE 14.96%. Taken on their own, these numbers offer context rather than a trading signal.
Gland Pharma Ltd. has a market capitalisation of Rs 47,417.52 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.58x, P/B at 4.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.69%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 42.58x |
| Benchmark Median P/E | 31.79x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.58x to 668.09x |
| Company P/B Ratio | 4.52x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 10.56% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 14.96% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 47,417.52 crore |
| Benchmark Median Market Cap | Rs 812.84 crore |
Gland Pharma Ltd. (GLAND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.58x, which is above the benchmark median of 31.79x, a difference of +33.94%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.73%, a difference of -9.97%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.63%, a difference of +9.76%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,34,279.63 | 35.35 | 4.94 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,737.12 | 83.61 | 13.85 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,81,129.27 | 82.93 | 20.15 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,239.13 | 25.16 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,08,808.05 | 31.97 | 3.07 | 11.83 | 16 |
Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.58x compared with the displayed peer median of 35.35x. The comparison is relative and should not be read as a recommendation. Its ROE of 10.56% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 47,417.52 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Gland Pharma
- Gland Pharma Share Price is up 2.16% today, with the stock trading at Rs 2,976 during market hours.
- Gland Pharma Share Price is backed by a market capitalisation of Rs 47,417.52 crore, which keeps it prominent in Healthcare.
- Gland Pharma Share Price carries a P/E of 42.58 and a P/B of 4.52, both useful for valuation checks.
- Gland Pharma Share Price shows ROE of 10.56% and ROCE of 14.96%, which investors can compare with sector norms.
- Gland Pharma Share Price remains relevant against listed pharma peers such as Sun Pharma, Divi’s Labs, Torrent Pharma, Zydus Lifesciences and Cipla.
About Gland Pharma
Gland Pharma Ltd. operates in the Healthcare sector within Pharmaceuticals & Drugs. Gland Pharma Share Price therefore reflects a business that sits in a highly monitored segment of Indian equity markets. The company’s valuation and market cap are important because pharma names are often assessed through a mix of earnings, book value, returns and relative positioning. For Gland Pharma Stock News readers, the company’s current profile is defined by the exact numbers now visible in the market rather than by any unsupported narrative.
On the financial side, Gland Pharma Share Price is tied to EPS of Rs 68.41, book value of Rs 644.16 and dividend yield of 0.69%, with ROE at 10.56% and ROCE at 14.96%. That makes Gland Pharma Fundamental Analysis a combination of profit-per-share, asset backing and return measures. In sector terms, Gland Pharma Share Price sits alongside large listed pharma peers and is often read in relation to industry valuation ranges. Univest data helps place that broader context in one view for investors tracking Gland Pharma Share Price, Gland Pharma Share Price Today and Gland Pharma Stock Performance.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Gland Pharma Share Price rising today?
Ans. Gland Pharma Share Price is rising today because it traded at Rs 2,976, up 2.16% from the previous close. Univest figures confirm the price action, but they do not point to a specific company trigger.
What is Gland Pharma Share Price today?
Ans. Gland Pharma Share Price today is Rs 2,976. The stock is trading above its previous close of Rs 2,913 and has moved within an intraday range of Rs 2,899.1 to Rs 2,977.4.
What is Gland Pharma market cap?
Ans. Gland Pharma market cap stands at Rs 47,417.52 crore. That places Gland Pharma Share Price well above the industry median market capitalisation in the same industry benchmark set of 198 companies.
What does Gland Pharma Fundamental Analysis show?
Ans. Gland Pharma Fundamental Analysis shows a P/E of 42.58, P/B of 4.52, ROE of 10.56%, ROCE of 14.96%, EPS of Rs 68.41 and book value of Rs 644.16, all useful for valuation context.
How does Gland Pharma compare with pharma peers?
Ans. Gland Pharma Share Price sits below Sun Pharma, Divi's Labs and Torrent Pharma on market cap, while its P/E is higher than Sun Pharma and Cipla but lower than Divi's Labs and Torrent Pharma.
What is the sector and industry for Gland Pharma?
Ans. Gland Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That industry context matters because Gland Pharma Share Price is being compared against a broad same-industry benchmark.
What are Gland Pharma’s EPS and book value?
Ans. Gland Pharma EPS is Rs 68.41 and book value is Rs 644.16. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.
Should investors track Gland Pharma Share Price on Univest?
Ans. Yes, investors can track Gland Pharma Share Price on Univest to monitor live price levels, fundamental ratios, market cap and sector context. That keeps Gland Pharma Share Price in one factual, easy-to-read view.
Track Gland Pharma Share Price on Univest
Use Gland Pharma Ltd. (GLAND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Gland Pharma Share Price on Univest for live levels, valuation ratios, 52-week levels and updated market insights. Gland Pharma Share Price Today can also be reviewed alongside company fundamentals, peer context and market cap in one place. For readers following Gland Pharma Share Price Update, Univest keeps the stock page focused on verified numbers and clear context.
